Trastuzumab pamirtecan, a HER2-targeted antibody-drug conjugate, achieved ‘exceptional’ antitumor responses in patients with recurrent endometrial cancer, especially those with HER2 IHC 3+ tumors.

Learn how to choose the right agentic AI pilot using a proven CIO framework. Discover AI pilot selection models, use cases, ...

Selma City Schools is gearing up for a summer of growth and exploration with the launch of two major student initiatives: the ...

At John Barry Elementary School, the veteran third-grade teaching team laughed and cried when they talked about their long ...

A naval blockade of Iran ordered by President Donald Trump has begun after the U.S. and Iran failed to come to an agreement ...

Building Kidz School (Building Kidz), a leader in early childhood education and a franchise rooted in making a meaningful ...

Despite a noisy Q1, high-quality munis continued to pay investors their interest and principal as intended. Muni yields rose ...

The World's Smallest, Lightest, Most Rugged Cinema Cameras Designed for Any Mission: MISSION 1 PRO— Featuring a Cutting-Edge ...

An essay about his late mother and engineering, four research projects he had undertaken and a passion for sports helped Le ...

This report was published by ChangeNOW, a comprehensive crypto ecosystem for B2C and B2B Web3 asset management.Executive ...

FORT WAYNE — Foellinger Foundation is providing up to $2 million for a program that two school district leaders say is ...